KRAS and NRAS genes mutations as biomarkers in the therapy of colorectal cancer and the basic methods of their detection

Determination of the mutations' status in the KRAS and NRAS genes is a necessary requirement in the treatment of patients with colorectal cancer (CRC). Patients with certain mutations in the KRAS and NRAS genes are resistant to anti-EGFR drug therapy and have a lower median survival rate than t...

Full description

Saved in:
Bibliographic Details
Main Authors: Olga I. Brovkina, Alexey G. Nikitin
Format: article
Language:RU
Published: Eco-vector 2021
Subjects:
R
Online Access:https://doaj.org/article/f188be48a67348c79d1798ffd8d2b72d
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items